Document is current
Any future updates will be listed below
-
Authors
Peyton, Shelly R. https://orcid.org/0000-0002-7364-8727
Chow, Lesley W.
Finley, Stacey D. https://orcid.org/0000-0001-6901-3692
Versypt, Ashlee N. Ford
Hill, Reginald
Kemp, Melissa L. https://orcid.org/0000-0003-3781-8802
Langer, Ellen M. https://orcid.org/0000-0003-0352-1859
McGuigan, Alison P. https://orcid.org/0000-0003-2803-0917
Meyer, Aaron S. https://orcid.org/0000-0003-4513-1840
Seidlits, Stephanie K.
Roy, Krishnendu https://orcid.org/0000-0002-9972-0950
Mumenthaler, Shannon M. https://orcid.org/0000-0003-2687-3769
- License Information
-
More Information
Article History
Accepted: 7 August 2023
First Online: 2 October 2023
Competing interests
: M.L.K. is a scientific advisory board member (with equity) for Parthenon Therapeutics. The other authors declare no competing interests.
